Bed wetting<unk>  is used to treat nocturnal enuresis (bedwetting). It is usually prescribed in the form of<unk>  acetate, by mouth. Children taking<unk>  have 2.2 fewer wet nights per week and are 4.5 times more likely to sleep without disruption compared with placebo. Nighttime urination In 2017, the FDA approved<unk>  has some benefit for adults who have problems with night time urination (known as nocturia). Bleeding disorders<unk> <unk>  is usually the first line treatment for mild to moderate type 1 von Willebrand disease. It is not recommended in severe disease or in those with abnormal factor VIII. Usefulness in type 2A, 2M, or 2N von Willebrand disease is variable. Generally not recommended in 2B and type 3 von Willebrand disease.<unk>  is only recommended in mild hemophilia A. It may be used both for bleeding due to trauma or to try to prevent bleeding due to surgery. It is not effective in the treatment of hemophilia B (factor IX deficiency) or severe hemophilia A. May also be used in uremia induced bleeding. Diabetes insipidus<unk>  is used in the treatment of central diabetes insipidus (DI) as a replacement for endogenous antidiuretic hormone (ADH) that is in insufficient quantity due to decreased or non-existent secretion or production of ADH by the posterior pituitary or hypothalamus, respectively. It is also used in the diagnostic workup for diabetes insipidus, in order to distinguish central from DI due to the kidneys.<unk>  is not effective at treating nephrogenic DI, thus a positive response is generally indicative of central DI.
Desmopressin
Platelet-rich plasma
Vasopressin
Vasopressin 
Prothrombin complex concentrate
Recombinant factor VIIa
Fresh frozen plasma
Efmoroctocog alfa